Seng Chin Mah

Biography

 Seng Chin Mah, PhD, is Chief Executive Officer of the Canyon Pharmaceuticals group. He has over 25 years of experience in the Pharma industry. Prior to joining Canyon Pharmaceuticals, Dr. Mah was recently Head of Development of the Integration Office during the integration of Chiron into Novartis, and has previously held positions including the Global Head of Clinical Safety & Epidemiology, Head of Drug Regulatory Affairs Europe. He also had oversight responsibility for Clinical Quality Assurance. Dr. Mah was also a member of the board for Novartis Europharm Ltd. During his tenure with Novartis and Ciba, Dr. Mah has driven transformational programs, managed large global organizations, and achieved significant business results such as the global registration of major products including Diovan. Dr. Mah has worked extensively on both development projects and marketed products. He has held numerous research and academia positions, and is currently on the boards of several biotech companies.

Research Interest

Clinical Quality Assurance Development projects and marketed products